Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Initiation of a formalized precision medicine program in gynecologic oncology.

Gynecologic oncology - 1 Apr 2016

Gunderson Camille C, Rowland Michelle R, Wright Deborah L, Andrade Kelsi L, Mannel Robert S, McMeekin D Scott, Moore Kathleen N

Abstract excerpt

OBJECTIVE: In an effort to better incorporate precision medicine into clinical practice, we initiated a pilot project to screen, discuss, and genetically characterize patients with metastatic or recurrent gynecologic malignancies for whom no curative standard of care exists. METHODS: In 7/2014, we initiated a multi-disciplinary Precision Medicine Board (PMB) whose purpose was to apply molecular profiling to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged
Share to Genital Neoplasms, Female

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Mutation

Share to Pilot Projects

Share to Precision Medicine

Source

Identifiers

PMID: 27016225
DOI: 10.1016/j.ygyno.2016.02.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Initiation of a formalized precision medicine program in gynecologic oncology.PMID 27016225Read ↗

Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real-World Precision Cancer Medicine Platform.Semantic proximity Read ↗

Rational selection of biomarker driven therapies for gynecologic cancers: The more we know, the more we know we don't know.Semantic proximity Read ↗

Hereditary gynecologic tumors and precision cancer medicine.Semantic proximity Read ↗

Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer.Semantic proximity Read ↗

Widespread adoption of precision anticancer therapies after implementation of pathologist-directed comprehensive genomic profiling across a large US health systemSemantic proximity Read ↗

Organ-specialty–led implementation of comprehensive genomic profiling in gynecological oncology: a nationwide survey in JapanSemantic proximity Read ↗

Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancerSemantic proximity Read ↗

Implementation of a Molecular Tumor Registry to Support the Adoption of Precision Oncology Within an Academic Medical Center: The Duke University ExperienceSemantic proximity Read ↗

Precision oncology: lessons learned and challenges for the futureSemantic proximity Read ↗

Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers.Semantic proximity Read ↗

A Precision Oncology Platform to Support Genotype-Tailored Therapy Selection.Semantic proximity Read ↗

Genome tumor profiling in endometrial cancer and clinical relevance in endometrial cancer management: a retrospective single-center experience.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.